Real-time enrollment status for this solid tumor clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:30 PM UTC
| NCT Number | NCT04939610 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumor |
| Phase | PHASE1 |
| Target Enrollment | 222 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | April 23, 2026 (Apr 23, 2026) |
As of July 17, 2026: Clinical trial NCT04939610 is currently recruiting participants. This phase1 study for solid tumor is actively seeking new participants at 20 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04939610 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04939610 was last updated Apr 23, 2026 (April 23, 2026). HelloStudys verifies this status automatically.